Brain, Vol 120, Issue 8 1315-1324, Copyright © 1997 by Oxford University Press
D Eidelberg, JR Moeller, K Kazumata, A Antonini, D Sterio, V Dhawan, P Spetsieris, R Alterman, PJ Kelly, M Dogali, E Fazzini and A Beric
We have used [18F]fluorodeoxyglucose and PET to identify specific metabolic
covariance patterns associated with Parkinson's disease and related
disorders previously. Nonetheless, the physiological correlates of these
abnormal patterns are unknown. In this study we used PET to measure resting
state glucose metabolism in 42 awake unmedicated Parkinson's disease
patients prior to unilateral stereotaxic pallidotomy for relief of
symptoms. Spontaneous single unit activity of the internal segment of the
globus pallidus (GPi) was recorded intraoperatively in the same patients
under identical conditions. The first 24 patients (Group A) were scanned on
an intermediate resolution tomograph (full width at half maximum, 8 mm);
the subsequent 18 patients (Group B) were scanned on a higher resolution
tomograph (full width half maximum, 4.2 mm). We found significant positive
correlations between GPi firing rates and thalamic glucose metabolism in
both patient groups (Group A: r = 0.41, P < 0.05; Group B: r = 0.69, P
< 0.005). In Group B, pixel-based analysis disclosed a significant focus
of physiological-metabolic correlation involving the ventral thalamus and
the GPi (statistical parametric map: P < 0.05, corrected). Regional
covariance analysis demonstrated that internal pallidal neuronal activity
correlated significantly (r = 0.65, P < 0.005) with the expression of a
unique network characterized by covarying pallidothalamic and brainstem
metabolic activity. Our findings suggest that the variability in pallidal
neuronal firing rates in Parkinson's disease patients is associated with
individual differences in the metabolic activity of efferent projection
systems.
ARTICLES
Metabolic correlates of pallidal neuronal activity in Parkinson's disease
Department of Neurology, North Shore University Hospital, Manhasset, NY, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Carbon, M. Niethammer, S. Peng, D. Raymond, V. Dhawan, T. Chaly, Y. Ma, S. Bressman, and D. Eidelberg Abnormal striatal and thalamic dopamine neurotransmission: Genotype-related features of dystonia Neurology, June 16, 2009; 72(24): 2097 - 2103. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Lin, M. Carbon, C. Tang, A. Y. Mogilner, D. Sterio, A. Beric, V. Dhawan, and D. Eidelberg Metabolic correlates of subthalamic nucleus activity in Parkinson's disease Brain, May 1, 2008; 131(5): 1373 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hirano, K. Asanuma, Y. Ma, C. Tang, A. Feigin, V. Dhawan, M. Carbon, and D. Eidelberg Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease J. Neurosci., April 16, 2008; 28(16): 4201 - 4209. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Feigin, M. G. Kaplitt, C. Tang, T. Lin, P. Mattis, V. Dhawan, M. J. During, and D. Eidelberg Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease PNAS, December 4, 2007; 104(49): 19559 - 19564. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Feigin, C. Tang, Y. Ma, P. Mattis, D. Zgaljardic, M. Guttman, J. S. Paulsen, V. Dhawan, and D. Eidelberg Thalamic metabolism and symptom onset in preclinical Huntington's disease Brain, November 1, 2007; 130(11): 2858 - 2867. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Huang, C. Tang, A. Feigin, M. Lesser, Y. Ma, M. Pourfar, V. Dhawan, and D. Eidelberg Changes in network activity with the progression of Parkinson's disease Brain, July 1, 2007; 130(7): 1834 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Asanuma, C. Tang, Y. Ma, V. Dhawan, P. Mattis, C. Edwards, M. G. Kaplitt, A. Feigin, and D. Eidelberg Network modulation in the treatment of Parkinson's disease Brain, October 1, 2006; 129(10): 2667 - 2678. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Van Laere, C. Casteels, L. De Ceuninck, B. Vanbilloen, A. Maes, L. Mortelmans, W. Vandenberghe, A. Verbruggen, and R. Dom Dual-Tracer Dopamine Transporter and Perfusion SPECT in Differential Diagnosis of Parkinsonism Using Template-Based Discriminant Analysis J. Nucl. Med., March 1, 2006; 47(3): 384 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ravina, D. Eidelberg, J. E. Ahlskog, R. L. Albin, D. J. Brooks, M. Carbon, V. Dhawan, A. Feigin, S. Fahn, M. Guttman, et al. The role of radiotracer imaging in Parkinson disease Neurology, January 25, 2005; 64(2): 208 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Kobylarz and N. D. Schiff Functional Imaging of Severely Brain-Injured Patients: Progress, Challenges, and Limitations Arch Neurol, September 1, 2004; 61(9): 1357 - 1360. [Full Text] [PDF] |
||||
![]() |
M. Carbon, S. Su, V. Dhawan, D. Raymond, S. Bressman, and D. Eidelberg Regional metabolism in primary torsion dystonia: Effects of penetrance and genotype Neurology, April 27, 2004; 62(8): 1384 - 1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Obeso, M. Rodriguez-Oroz, C. Marin, F. Alonso, I. Zamarbide, J. L. Lanciego, and M. Rodriguez-Diaz The origin of motor fluctuations in Parkinson's disease: Importance of dopaminergic innervation and basal ganglia circuits Neurology, January 13, 2004; 62(90011): S17 - 30. [Abstract] [Full Text] |
||||
![]() |
K. J. Black, T. Hershey, J. M. Koller, T. O. Videen, M. A. Mintun, J. L. Price, and J. S. Perlmutter A possible substrate for dopamine-related changes in mood and behavior: Prefrontal and limbic effects of a D3-preferring dopamine agonist PNAS, December 24, 2002; 99(26): 17113 - 17118. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Feigin, M. F. Ghilardi, M. Fukuda, M. J. Mentis, V. Dhawan, A. Barnes, C. P. Ghez, and D. Eidelberg Effects of levodopa infusion on motor activation responses in Parkinson's disease Neurology, July 23, 2002; 59(2): 220 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Levy, W. D. Hutchison, A. M. Lozano, and J. O. Dostrovsky Synchronized Neuronal Discharge in the Basal Ganglia of Parkinsonian Patients Is Limited to Oscillatory Activity J. Neurosci., April 1, 2002; 22(7): 2855 - 2861. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Feigin, M. Fukuda, V. Dhawan, S. Przedborski, V. Jackson-Lewis, M.J. Mentis, J.R. Moeller, and D. Eidelberg Metabolic correlates of levodopa response in Parkinson's disease Neurology, December 11, 2001; 57(11): 2083 - 2088. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Feigin, K. L. Leenders, J. R. Moeller, J. Missimer, G. Kuenig, P. Spetsieris, A. Antonini, and D. Eidelberg Metabolic Network Abnormalities in Early Huntington's Disease: An [18F]FDG PET Study J. Nucl. Med., November 1, 2001; 42(11): 1591 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuda, M. J. Mentis, Y. Ma, V. Dhawan, A. Antonini, A. E. Lang, A. M. Lozano, J. Hammerstad, K. Lyons, W. C. Koller, et al. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: A PET study of resting-state glucose metabolism Brain, August 1, 2001; 124(8): 1601 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hutchinson, T. Nakamura, J. R. Moeller, A. Antonini, A. Belakhlef, V. Dhawan, and D. Eidelberg The metabolic topography of essential blepharospasm: A focal dystonia with general implications Neurology, September 12, 2000; 55(5): 673 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Black, T. Hershey, M. H. Gado, and J. S. Perlmutter Dopamine D1 Agonist Activates Temporal Lobe Structures in Primates J Neurophysiol, July 1, 2000; 84(1): 549 - 557. [Abstract] [Full Text] [PDF] |
||||






